Font Size:
a
A
A
Keyword [non-Hodgkin lymphoma]
Result: 141 - 160 | Page: 8 of 9
141.
The interaction between Bcl-6 and STAT6 pathway in non-Hodgkin lymphoma
142.
Hair-coloring product use, agricultural pesticide exposure, blood transfusion and risk of non-Hodgkin lymphoma
143.
Common immune-related factors and risk of non-Hodgkin lymphoma
144.
TP73 in Non-Hodgkin lymphoma pathogenesis and therapy
145.
The Anti-tumor Effect Of MiR-28-5p Targeting BECN1 In DLBCL Cells And The Anti-tumor Mechanism Of Curcumin
146.
Prognostic Significance Of Liver Function Markers In Secondary Hemophagocytic Lymphohistiocytosis
147.
Study On The Correlation Between The Blood Lymphocyte Morphology And Subpopulation Characteristics Andthe Diagnosis Of Non-hodgkin Lymphoma
148.
Clinical Study Of Targeting CD19 Fourth-generation Chimeric Antigen Receptor T Cells In Treating Relapsed Or Refractory B Cell Non-hodgkin Lymphoma
149.
Clinical Characteristics And Prognostic Analysis Of Primary Extranodal Non-hodgkin Lymphoma Of The Head And Neck
150.
The Clinical Characteristics And Prognostic Factors Of Primary Intestinal Lymphoma:a Retrospective Analysis
151.
Analysis Of Clinical Features And Prognostic Relevant Factors Of Intestinal Non-hodgkin Lymphoma
152.
Biomimetic Construction Of Erythrocyte Membrane Camouflage Nanosystem And Anti-B-cell Lymphoma Study
153.
Application Of Urine Proteomics In The Diagnosis And Efficacy Evaluation Of Early-stage Mycosis Fungoides
154.
Study On The Effect Of CHN1 On The Prognosis Of B-NHL And Its Mechanism Of Actio
155.
Construction And Application Of Self-management Intervention Scheme For Patients With Non-Hodgkin Lymphoma Chemotherapy Based On IKAP Model
156.
The Clinical Characteristics And Prognostic Analysis Of Indolent B-cell Non-Hodgkin Lymphoma:a Retrospective Study Of 345 Cases
157.
The Role And Mechanism Of LHPP In B-cell Non-hodgkin Lymphoma
158.
Clinical Epidemiological Analysis Of Non-Hodgkin Lymphoma With Cervical Mass As The First Symptom
159.
Expression And Clinical Significance Of NLR,LDH And β2-MG In Peripheral Blood With Non-Hodgkin Lymphoma
160.
Correlation Analysis Between Maximum Standard PETCT Intake And Clinicopathological Parameters Before Treatment Of Non-hodgkin’s Lymphoma
<<First
<Prev
Next>
Last>>
Jump to